177 related articles for article (PubMed ID: 21915624)
1. Processed blood volume impacts clinical efficacy in patients with ulcerative colitis undergoing adsorptive depletion of myeloid lineage leucocytes.
Yoshimura N; Tadami T; Kawaguchi T; Sako M; Yoshimoto H; Yamaka T; Takazoe M
J Gastroenterol; 2012 Jan; 47(1):49-55. PubMed ID: 21915624
[TBL] [Abstract][Full Text] [Related]
2. Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
Kikuyama R; Fukunaga K; Kawai M; Yokoyama Y; Kamikozuru K; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kato K; Kono T; Nogami K; Nagase K; Nakamura S; Takei Y; Miwa H; Matsumoto T
Ther Apher Dial; 2011 Aug; 15(4):360-6. PubMed ID: 21884470
[TBL] [Abstract][Full Text] [Related]
3. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy.
Li N; Mao J; Tang H; Zhu L; Tan X; Bi J; Wu H; Chen X; Wang Y
J Clin Apher; 2020 Aug; 35(4):271-280. PubMed ID: 32378240
[TBL] [Abstract][Full Text] [Related]
5. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.
Tominaga K; Nakano M; Hoshino M; Kanke K; Hiraishi H
BMC Gastroenterol; 2013 Mar; 13():41. PubMed ID: 23452668
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Yokoyama Y; Watanabe K; Ito H; Nishishita M; Sawada K; Okuyama Y; Okazaki K; Fujii H; Nakase H; Masuda T; Fukunaga K; Andoh A; Nakamura S
Cytotherapy; 2015 May; 17(5):680-8. PubMed ID: 25804800
[TBL] [Abstract][Full Text] [Related]
8. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.
Takeda S; Sato T; Katsuno T; Nakagawa T; Noguchi Y; Yokosuka O; Saito Y
Dig Dis Sci; 2010 Jul; 55(7):1886-95. PubMed ID: 19908144
[TBL] [Abstract][Full Text] [Related]
9. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
[TBL] [Abstract][Full Text] [Related]
10. Adsorptive Depletion of Myeloid Lineage Leucocytes as Remission Induction Therapy in Patients with Ulcerative Colitis after Failure of First-Line Medications: Results from a Three-Year Real World, Clinical Practice.
Iida T; Ikeya K; Kato M; Abe J; Yamamoto M; Watanabe F; Sugimoto K; Hanai H
Digestion; 2017; 96(2):119-126. PubMed ID: 28796990
[TBL] [Abstract][Full Text] [Related]
11. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
[TBL] [Abstract][Full Text] [Related]
12. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.
Yokoyama Y; Kawai M; Fukunaga K; Kamikozuru K; Nagase K; Nogami K; Kono T; Ohda Y; Iimuro M; Hida N; Nakamura S; Miwa H; Matsumoto T
BMC Gastroenterol; 2013 Feb; 13():27. PubMed ID: 23399416
[TBL] [Abstract][Full Text] [Related]
13. Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort study.
Shimoyama T; Yamamoto T; Umegae S; Matsumoto K
BMC Gastroenterol; 2018 Aug; 18(1):120. PubMed ID: 30068300
[TBL] [Abstract][Full Text] [Related]
14. A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Yamamoto T; Iida T; Ikeya K; Kato M; Matsuura A; Tamura S; Takano R; Tani S; Osawa S; Sugimoto K; Shimoyama T; Hanai H
Clin Transl Gastroenterol; 2018 Jul; 9(7):170. PubMed ID: 29977035
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
[TBL] [Abstract][Full Text] [Related]
16. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
[TBL] [Abstract][Full Text] [Related]
17. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.
Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR
Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857
[TBL] [Abstract][Full Text] [Related]
18. Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study.
Yamamoto T; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2010 Nov; 16(11):1905-11. PubMed ID: 20310015
[TBL] [Abstract][Full Text] [Related]
19. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study.
Yamamoto T; Umegae S; Matsumoto K
J Gastroenterol; 2011 Aug; 46(8):1003-9. PubMed ID: 21681409
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
